chronic limb-threatening ischemia research hub

Efficacy of combined treatment by autologous cell therapy and percutaneous transluminal angioplasty (PTA) versus the treatment by isolated PTA in diabetic patients with chronic limb-threatening ischemia

This study is looking at a new way to treat severe circulation problems in the legs of people with diabetes. It compares traditional balloon treatment with a new approach using the patient's own cells to see if it can help save more limbs and heal wounds.

A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the recommended phase-2 dose of AUP1602-C in two dosing frequencies as a topical treatment for non-healing neuro-ischemic diabetic foot ulcers